CytoTronics
Drug Discovery
$13.5Mlatest round · Seed · Mar 2024 · 2 yr ago
1backers · Draper Associates
22team · US Form 5500 (plan participants) · Dec 2024
2020founded
Overview
Visualize live cell function at scale with Pixel™: power cell biology discovery with insights on viability, morphology, ephys, & more.
Funding and backers
Total raised
$13.5M
1 round on record
Latest round
$13.5M
Seed · Mar 2024 · 2 yr ago
Team
22
US Form 5500 (plan participants) · Dec 2024
Backers
1
Draper Associates
The money's age
Long since its last round
31 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 8, 2025
Launched CytoTronics Launches Neural Application for Pixel, Unleashing High-throughput Screening Capability in Drug Discovery for Neurological Disease · cytotronics.com
Mar 22, 2024
Raised a round Seed $13.5M · SEC Form D
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Seed | Mar 2024 | $13.5M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | CytoTronics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Jeffrey AbbottExecutive Officer, DirectorSEC Form D
Wenxuan WuExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Nosis Bio delivers breakthrough receptor-targeted RNA medicines through cutting-edge physics-aware deep learning, single cell biology, and…
TenSixty Biosciences expands the druggable oncology universe through epitope-level targeting and a biology-first therapeutic discovery…
From tissue biology to oncology decisions. Spatial Medicine connects how cells are organized and interact within tissue to decisions about…
Welcome to the first map of human biology. Parallel Bio reimagined the entire drug discovery process from the ground up - creating a system…
Human iPSC-derived hepatocytes, organoids and AI-powered Cell Painting for predictive drug discovery. Trusted by AstraZeneca, Sanofi, Deep…
Discover our non-toxic dyes for live-cell imaging. Saguaro dyes are data-rich and do not require any wash step, pushing beyond the limits…
Visa sponsorship
0
H-1B filings in 12 months
0
Open roles in United States
In the register as CytoTronics, Inc., Boston, MA
Other sponsors in the same field
Genentech 
Exelixis 
Schrodinger 
Generate:Biomedicines
Alert me
US Department of Labor · latest filing Apr 21, 2025 · Visa details by country
Financials
Total raised
$13.5M
Latest round
Seed
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Seed | 2024 | $13.5M | Details |
People
Jeffrey Abbott
Executive Officer, Director
Wenxuan Wu
Executive Officer, Director
Sameer Rohatgi
Director
Douglas Kahn
Director
Jenna Abelli
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Draper AssociatesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Axion BioSystems Acquires High-Throughput, High-Density CMOS MEA Technology from CytoTronics
ATLANTA, GA, January 22nd, 2026-(BUSINESS WIRE)-Axion BioSystems, a leading life sciences tools company focused on cutting-edge live-cell bioelectronic assay and imaging systems, announces the acquisition of the intellectual property and assets of CytoTro
Read more
Report
Axion BioSystems Buys CytoTronics' High Density CMOS Microelectrode Array Platform For Drug Discovery
Axion BioSystems has acquired the intellectual property and assets of CytoTronics, adding high-density microelectrode array technology originally developed at Harvard University to Axion's portfolio of live-cell bioelectronic assay and imaging systems.
Read more
Report
Axion BioSystems Acquires High-Throughput, High-Density CMOS MEA Technology from CytoTronics
ATLANTA, January 22, 2026--Axion BioSystems, a leading life sciences tools company focused on cutting-edge live-cell bioelectronic assay and imaging systems, announces the acquisition of the intellectual property and assets of CytoTronics, Inc. The purcha
Read more
Report
CytoTronics Expands Pixel Capability with Multi-modal Cardiac Application for Early Screening of Drug Candidates in Cardiovascular Research
New application consolidates multiple assays into one multiplexed assay that measures cardiomyocyte electrical activity, contractility and cell morphology simultaneously, giving researchers immediate insight on how signals propagate across heart tissue. C
Read more
Report
CytoTronics Launches Neural Application for Pixel, Unleashing High-throughput Screening Capability in Drug Discovery for Neurological Disease
First-of-its-kind application for simultaneous measurement of neural structure and activity at scale in 96- and 384-well plates enables discovery of more efficacious medicines for neurodegenerative disease. CytoTronics, Inc., a pioneer of semiconductor-ba
Read more
Report
CytoTronics Launches Neural Application for Pixel, Unleashing High-throughput Screening Capability in Drug Discovery for Neurological Disease
Read more
Report
CytoTronics Secures $13.5M Series Seed 2 Financing to Speed Market Entry of Pixel System for Breakthroughs in Cell Biology
Company welcomes life science industry veteran Sameer Rohatgi to Board of Directors CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, today announced a $13.5 million seed extension financing and the appointment o
Read more
Report
CytoTronics: Cell Biology Discovery Tech Company Raises $13.5 Million (Seed Extension)
CytoTronics, a pioneer of semiconductor-based platforms for discovery in cell biology, announced a $13.5 million seed extension financing and the appointment of Sameer Rohatgi of LYFE Capital to their Board of Directors.
Read more
Report
CytoTronics获得1350万美元天使轮融资_腾讯新闻
CytoTronics是一家CMOS驱动的药物发现平台通过其互补金属氧化物半导体(CMOS)电子平台实现了用于药物发现的无光学成像该平台以一套技术为基础测量和操纵活细胞以产生实时、高分辨率的基于电和电化学细胞的分析近日CytoTronics获得1350万美元天使轮融资LYFE Capital洲嶺资本、Anzu Partners、联想之星、Draper...
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston
United States
HQ
CytoTronics, Inc.
50-200 est. staff
12 Farnsworth St., Boston, MA 02210